Table 1.
Clinicopathological characteristics of patients with primary invasive breast cancer and ovarian metastases
Clinicopathological characteristics | N = 46 | % |
---|---|---|
Age at diagnosis of breast cancer, years - median (range) | 36.5 (28–40) | - |
BRCA gene mutation | ||
No | 8 | 17.4 |
Yes, BRCA 1 | 1 | 2.2 |
Yes, BRCA 2 | 0 | 0.0 |
Unknown | 37 | 80.4 |
Breast tumor localization | ||
Left | 23 | 50.0 |
Right | 21 | 45.7 |
Both | 2 | 4.3 |
Most extensively performed breast surgery | ||
Needle biopsy | 4 | 8.7 |
Breast conserving surgery | 15 | 32.6 |
Mastectomy | 27 | 58.7 |
Breast tumor histological subtype | ||
Ductal | 36 | 78.2 |
Lobular | 5 | 10.9 |
Ductolobular | 5 | 10.9 |
Scarff-Bloom-Richardson grade | ||
I | 4 | 8.7 |
II | 19 | 41.3 |
III | 15 | 32.6 |
Unknown | 8 | 17.4 |
Estrogen receptor | ||
Negative | 5 | 10.9 |
Positive | 41 | 89.1 |
Progesterone receptor | ||
Negative | 8 | 17.4 |
Positive | 38 | 82.6 |
Her2/neu receptor | ||
Negative | 38 | 82.6 |
Positive | 8 | 17.4 |
Tumor stage | ||
T1 | 11 | 23.9 |
T2 | 24 | 52.2 |
T3 | 7 | 15.2 |
T4 | 4 | 8.7 |
Nodal stage | ||
N0 | 14 | 30.4 |
N1 | 12 | 26.1 |
N2 | 10 | 21.7 |
N3 | 10 | 21.7 |
Distant metastasis | ||
cM0 | 39 | 84.8 |
cM1 | 7 | 15.2 |
Age at diagnosis of ovarian metastases, years - median (range) | 40.0 (31–51) | - |
Time between breast cancer and ovarian metastases, months - median (range) | 41.9 (0.3–141.8) | - |
Recurrent disease prior to oophorectomy | ||
No | 15 | 32.6 |
Yes, locoregional recurrence | 12 | 26.1 |
Yes, distant recurrence | 19 | 41.3 |
Type of ovarian surgery | ||
Unilateral oophorectomy | 0 | 0.0 |
Bilateral oophorectomy | 46 | 100.0 |
Indication for oophorectomy | ||
Prophylactic because of breast cancer | 9 | 19.6 |
Therapeutic because of breast cancer | 25 | 54.3 |
Abnormal ovaries on ultrasound | 12 | 26.1 |
Localization of ovarian metastases | ||
Left | 4 | 8.7 |
Right | 6 | 13.0 |
Both | 29 | 63.0 |
Unknown | 7 | 15.2 |